- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.6: 4 residues within 4Å:- Chain A: A.703, E.1069, K.1070, N.1071
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.15: 3 residues within 4Å:- Chain B: A.703, E.1069, N.1071
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.23: 2 residues within 4Å:- Chain C: A.703, N.1071
No protein-ligand interaction detected (PLIP)- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-MAN.7: 4 residues within 4Å:- Chain A: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.8: 1 residues within 4Å:- Chain A: N.1131
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.16: 4 residues within 4Å:- Chain B: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.17: 1 residues within 4Å:- Chain B: N.1131
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.24: 4 residues within 4Å:- Chain C: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.25: 1 residues within 4Å:- Chain C: N.1131
No protein-ligand interaction detected (PLIP)- 32 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
NAG.26: 1 residues within 4Å:- Chain A: N.61
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain A: N.120, T.122, N.123, F.154
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain A: K.144, N.146
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain A: E.130, N.162
- Chain C: Y.393
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain A: N.231
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain A: N.279
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: N.340, V.364
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain A: N.600, T.601
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain A: N.654
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain A: N.706
- Chain B: D.793
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain A: N.1155
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain B: N.61
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain B: K.144, N.146
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain A: Y.393
- Chain B: N.162
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain B: G.229, I.230, N.231
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: N.328, T.330, Q.577
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: G.336, N.340, S.368
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.600
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain B: N.654
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain B: N.706, G.1128
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain B: N.1155, P.1159
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.61
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: N.120, T.122, N.123
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain C: K.144, N.146, S.148
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain C: N.162
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain B: E.462
- Chain C: N.231
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain C: N.279
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain C: N.340, V.364, L.365
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.600
Ligand excluded by PLIPNAG.55: 1 residues within 4Å:- Chain C: N.654
Ligand excluded by PLIPNAG.56: 5 residues within 4Å:- Chain A: I.791, D.793
- Chain C: S.705, N.706, G.1128
Ligand excluded by PLIPNAG.57: 1 residues within 4Å:- Chain C: N.1155
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cai, Y. et al., Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science (2021)
- Release Date
- 2021-07-07
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 32 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cai, Y. et al., Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science (2021)
- Release Date
- 2021-07-07
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C